Repurposing of therapeutic antibodies against dengue virus envelope protein receptor binding domain
Archives of Microbiology · 2024
DOI: 10.1007/s00203-024-04039-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Microbiology, 2024. Verfasst von Dwaipayan Chaudhuri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Presidency University, 86/1 College Street, Kolkata, 700073, India. Hauptthemen laut MEDLINE: Dengue Virus, Viral Envelope Proteins, Molecular Dynamics Simulation, Antibodies, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, Presidency University, 86/1 College Street, Kolkata, 700073, India.
- Department of Life Sciences, Presidency University, 86/1 College Street, Kolkata, 700073, India. kalyan.dbs@presiuniv.ac.in.
Zitieren
APA
Chaudhuri, D., Majumder, S., Datta, J., & Giri, K. (2024). Repurposing of therapeutic antibodies against dengue virus envelope protein receptor binding domain. Archives of Microbiology. https://doi.org/10.1007/s00203-024-04039-8
Vancouver
Chaudhuri D, Majumder S, Datta J, Giri K. Repurposing of therapeutic antibodies against dengue virus envelope protein receptor binding domain. Archives of Microbiology. 2024. doi:10.1007/s00203-024-04039-8
BibTeX
@article{Chaudhuri2024,
author = {Chaudhuri, Dwaipayan and Majumder, Satyabrata and Datta, Joyeeta and Giri, Kalyan},
title = {Repurposing of therapeutic antibodies against dengue virus envelope protein receptor binding domain},
journal = {Archives of Microbiology},
year = {2024},
doi = {10.1007/s00203-024-04039-8}
}
EUVIMED